21 completed, 9 terminated, 3 unknown, 2 recruiting. 36 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 36 | Completed 21, Terminated 9, Unknown 3, Recruiting 2, Withdrawn 1 |
Follow Paralysis: new trials by email Literature Review of Paralysis trials Research Report on Paralysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison Between Palpatory and Ultrasound-guided Methods for Botulinum Toxin Administration in Spastic Paraplegia AbobotulinumtoxinA - Ultrasound-Guided Technique, AbobotulinumtoxinA - Conventional Technique - Spastic Paraplegia | Phase 4 | Recruiting | Universidade Federal Fluminense | 40 | 2026-04-22 | 2026-09-03 |
| Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy GLP-1 medication - Diabetes Mellitus, Type 2, Obesity | Phase 4 | Completed | The Cleveland Clinic | 69 | 2024-07-31 | 2025-12-05 |
| Comparison of Botulinum Toxin Injection Techniques in Spasticity Onabotulinumtoxina for Injection - Spastic Hemiplegia | Phase 4 | Unknown | Konya Beyhekim Training and Research Hospital | 60 | 2022-12-01 | 2022-11-14 |
| Comparison of the Efficacy of Ultrasound Guided vs Non-guided Suprascapular Nerve Block Treatment in Stroke Patients Ultrasound-guided Suprascapular Nerve Block, Anatomical Landmark-guided Suprascapular Nerve Block - Hemiplegia, Stroke | Phase 4 | Recruiting | Abant Izzet Baysal University | 50 | 2022-03-15 | 2025-02-27 |
| Anterior Suprascapular Nerve Block is an Effective and Diaphragm Protective Approach for Arthroscopic Shoulder Surgery Evaluation of Diaphragm Movement - Diaphragm Paralysis Due to Local Anesthesia, Anterior Suprascapular Nerve Block | Phase 4 | Completed | Alper Tunga Dogan | 50 | 2020-12-01 | 2021-11-30 |
| Trial of Parkinson's And Zoledronic Acid Zoledronic Acid 5Mg/Bag 100Ml Inj, Placebo - Parkinson Disease, Osteoporosis | Phase 4 | Completed | California Pacific Medical Center Research Institute | 2721 | 2019-11-15 | 2026-06-25 |
| The Treatment of Shoulder Pain in Hemiplegic Spastic Patients With Botulinum Toxin A AbobotulinumtoxinA, Saline - Shoulder Pain | Phase 4 | Completed | Faculdade de Ciências Médicas da Santa Casa de São Paulo | 24 | 2019-06-05 | 2021-09-21 |
| Treatment of Disturbed Sleep in Progressive Supranuclear Palsy (PSP) Suvorexant, Zolpidem, Placebo oral capsule - Progressive Supranuclear Palsy(PSP), Insomnia | Phase 4 | Completed | University of California, San Francisco | 40 | 2019-06-02 | 2026-09-01 |
| Evaluation of Cortisone Treatment in Children With Acute Facial Nerve Palsy Prednisolone, Placebo Oral Tablet - Facial Palsy, Facial Nerve Diseases | Phase 4 | Completed | Dalarna County Council, Sweden | 343 | 2019-05-03 | 2026-09-02 |
| The Effect of Oral Baclofen and Botulinum Toxin Treatments in Hemiplegic Spasticity on the Nociceptive Flexor Reflex Nociceptor flexor reflex, Botox, Baclofen - Stroke Sequelae, Spastic Hemiplegia | Phase 4 | Completed | Mustafa Kemal University | 29 | 2018-05-26 | 2021-06-18 |
| Administration of Platelet-rich Fibrin to Autologous Fat Tissue in Injection Laryngoplasty for Vocal Cord Paralysis Injection Laryngoplasty with Platelet-rich Fibrin and Autologous Fat, Injection Laryngoplasty with Autologous Fat - Vocal Cord Paralysis | Phase 4 | Completed | Fakultas Kedokteran Universitas Indonesia | 19 | 2018-01-01 | 2021-04-20 |
| The Study of Pharmacokinetics and Pharmacodynamics of Cisatracurium cisatracurium - Critical Illness, Respiratory Distress Syndrome, Adult | Phase 4 | Completed | Mahidol University | 10 | 2017-12-15 | 2019-03-06 |
| Study to Evaluate Effects of DYSPORT® Injected in Lower and Upper Limb Combined With Guided Self-Rehabilitation Contract (GSC) Botulinum toxin type A, GSC - Spastic Hemiparesis | Phase 4 | Completed | Ipsen | 157 | 2016-12-18 | 2025-02-19 |
| Albuterol to Improve Respiratory Strength in SCI Oral Albuterol Extended Release, Placebo - Spinal Cord Injury, Respiratory Muscle Weakness | Phase 4 | Terminated | VA Office of Research and Development | 1 | 2016-06-01 | 2024-05-07 |
| Hand Rehabilitation Using Botulinum Toxin and Functional Electrical Stimulation-pilot Study Botulinum Toxin Type A 100 unit/Vial (Product) - Stroke, Spastic Hemiparesis | Phase 4 | Completed | National Rehabilitation Center, Seoul, Korea | 20 | 2016-05-18 | 2018-06-08 |
| Thermoregulation and Cognition During Cool Ambient Exposure in Tetraplegia Midodrine Hydrochloride, Cool Temperature - Tetraplegia, Hypothermia | Phase 4 | Completed | James J. Peters Veterans Affairs Medical Center | 30 | 2015-04-01 | 2025-03-21 |
| Effectiveness of Acetazolamide in Reducing Paralysis of the Leg in Patients Undergoing Aortic Aneurysm Surgery Surgery Acetazolamide - Thoracic Aneurysm | Phase 4 | Unknown | Liverpool Heart and Chest Hospital NHS Foundation Trust | 100 | 2014-07-01 | 2014-12-31 |
| Omega-3 Supplementation for Tetraplegics With Poor Cholesterol Levels Omega-3 supplements - Spinal Cord Injury, Tetraplegia | Phase 4 | Completed | University of Manitoba | 21 | 2013-07-01 | 2017-05-04 |
| Reinnervation of Facial Muscles After Lengthening Temporalis Myoplasty injection of 1% lidocaine, 2mL for facial nerve block - Facial Paresis | Phase 4 | Terminated | University Hospital, Caen | 10 | 2013-04-01 | 2016-05-25 |
| Haloperidol vs Conventional Therapy for Gastroparesis Haloperidol, Conventional Therapy - Gastroparesis | Phase 4 | Terminated | The University of Texas Health Science Center, Houston | 36 | 2012-11-01 | 2017-08-17 |
Showing 20 of 36. Sign in to see all of them.
Gastroparesis (10) · Quadriplegia (8) · Hemiplegia (6) · Spinal Cord Injuries (5) · Diabetes Mellitus (3) · Facial Paralysis (3) · Cognitive Dysfunction (2) · Hypothermia (2) · Paraplegia (2) · Sleep Initiation and Maintenance Disorders (2) · Stomach Diseases (2) · Stroke (2) · Supranuclear Palsy, Progressive (2) · Agnosia (1)
Pathological Conditions, Signs and Symptoms (36) · Neurologic Manifestations (35) · Signs and Symptoms (35) · Nervous System Diseases (27) · Central Nervous System Diseases (10) · Digestive System Diseases (9) · Gastrointestinal Diseases (9) · Stomach Diseases (8) · Wounds and Injuries (7) · Cranial Nerve Diseases (6) · Trauma, Nervous System (6) · Brain Diseases (5) · Mental Disorders (5) · Metabolic Diseases (5)
Botulinum Toxins, Type A (4) · abobotulinumtoxinA (3) · Baclofen (2) · Cisapride (2) · Midodrine (2) · Tablets (2) · Acetazolamide (1) · Albuterol (1) · Esomeprazole (1) · Haloperidol (1) · Injections (1) · Lidocaine (1) · Liraglutide (1) · Neostigmine (1) · Pharmaceutical Preparations (1)
James J. Peters Veterans Affairs Medical Center (2) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2) · Abant Izzet Baysal University (1) · Alper Tunga Dogan (1) · Aurolab (1) · California Pacific Medical Center Research Institute (1) · Chinese University of Hong Kong (1) · Columbia University (1) · Dalarna County Council, Sweden (1) · Faculdade de Ciências Médicas da Santa Casa de São Paulo (1) · Fakultas Kedokteran Universitas Indonesia (1) · Ipsen (1) · Konya Beyhekim Training and Research Hospital (1) · Liverpool Heart and Chest Hospital NHS Foundation Trust (1) · Mahidol University (1)
United States (14) · Turkey (Türkiye) (4) · France (3) · Brazil (2) · Canada (2) · Belgium (1) · Czechia (1) · Hong Kong (1) · India (1) · Indonesia (1) · Israel (1) · Russia (1) · Sweden (1) · Thailand (1) · United Kingdom (1)
John P Handrakis, PT, DPT, EdD (2) · Barbro Hedin Skogman, MD, PhD (1) · Carlos J Roldan, MD (1) · Dennis L. Fowler, M.D. (1) · Fauziah Fardizza, SpTHT-KL(K) (1) · Greg Schilero, MD (1) · Jamie M. Zeitzer, PhD (1) · John M Wo, MD (1) · Joon-Ho Shin, MS (1) · Justin C.Y. Wu, MBChB(CUHK) (1) · Karen Ethans, MD (1) · Mark Field, DPhil, MBBCh (1)
PMID 19925497, PMID 24090266, PMID 25531297, PMID 28257388, PMID 28632682, PMID 28646590, PMID 28973094, PMID 29634491, PMID 31541010, PMID 33649343, PMID 33947355, PMID 34039905, PMID 35065599, PMID 36870274, PMID 36919944, PMID 39343047, PMID 41837981
2016 (1), 2017 (1), R01AG059417 (1)